From the Ocular Oncology Service, Wills Eye Institute, Thomas Jefferson University, Philadelphia, Pennsylvania.
Supported by the Retina Research Foundation of the Retina Society, Cape Town, South Africa (C.L.S.); the Paul Kayser International Award of Merit in Retina Research, Houston, TX (J.A.S.); a donation from Michael, Bruce, and Ellen Ratner, New York, NY (J.A.S., C.L.S.); Mellon Charitable Giving from the Martha W. Rogers Charitable Trust, Philadelphia, PA (C.L.S.); the LuEsther Mertz Retina Research Foundation, New York, NY (C.L.S.); and the Eye Tumor Research Foundation, Philadelphia, PA (C.L.S., J.A.S.).
C.L.S. has had full access to all the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis.
Reprint requests: Carol L. Shields, MD, Ocular Oncology Service, Suite 1440, Wills Eye Institute, 840 Walnut Street, Philadelphia, PA 19107; e-mail: [email protected]
